• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Treatment time and circadian genotype interact to alter the severity of radiotherapy side-effects

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Talbot, C.
    Webb, A.
    Harper, E.
    Azria, D.
    Choudhury, Ananya
    de Ruysscher, D.
    Dunning, A.
    Elliott, R.
    Kerns, S.
    Lambrecht, M.
    Rancati, T.
    Rosenstein, B.
    Seibold, P.
    Sperk, E.
    Vega, A.
    Veldeman, L.
    Chang-Claude, J.
    West, Catharine M L
    Rattay, T.
    Symonds, R. P.
    Show allShow less
    Affiliation
    University of Leicester, Leicester Cancer Research Centre, Leicester
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Circadian rhythm influences a wide range of biological processes, including efficacy and side effects of cancer treatment. Earlier evidence disagrees on whether risk of radiotherapy side-effects is affected by treatment time, probably due to differences in organs irradiated and time analysis methods. We previously showed an interactive effect of time and genotype of circadian rhythm genes on late toxicity after breast radiotherapy. This study aimed to validate those results in a larger multi-centre cohort with a more sophisticated time analysis and more SNPs. Materials and Methods We collected time of each radiotherapy fraction from patients in REQUITE breast cancer cohorts. Requite was a multi centre, prospective study in Europe and US (www.requite.eu). Enrolment was open for two and a half years through 26 centres in eight countries. Radiotherapy toxicity data was collected at baseline, after radiotherapy and one & two years later. Genome-wide SNP data was available typed with Illumina OncoArrays. The primary endpoints used were acute erythema and late breast atrophy assessed by CTCAE v4. 1690 breast cancer patients with complete clinical and SNP data were included in the analysis. Local date-times for each fraction were converted into solar times as continuous predictors. Genetic chronotype markers were included in logistic regression analyses to identify predictors of each end-point. Results Significant predictors for acute erythema included BMI, breast radiation dose and PER3 genotype. There was weak evidence for an effect of treatment time on acute toxicity, but with no interaction between time and genotype. In the late toxicity analysis BMI, breast radiation dose, surgery type, mean treatment time and SNPs in CLOCK (rs1801260), PER3 (rs2087947) and RASD1 (rs11545787) genes predicted late breast atrophy (p<0×05). There was a significant interaction between time and the genotypes of the circadian rhythm genes (p=0.005-0.02), with peak time for toxicity determined by genotype. Conclusion Late atrophy could be reduce by selecting the optimal treatment time based on the genotypes of circadian genes (Figure 1). For example, PER3 rs2087947C/C genotypes should be treated in the morning; T/T in the afternoon. We predict triple homozygous patients (who are 14% of this cohort) would reduce their chance of atrophy from 70% to 33% by treating in the morning instead of afternoon. Future clinical trials could stratify patients treated at optimal times compared to those scheduled conventionally to determine the magnitude of patient benefit.
    Citation
    Talbot C, Webb A, Harper E, Azria D, Choudhury A, de Ruysscher D, et al. Treatment time and circadian genotype interact to alter the severity of radiotherapy side-effects. Radiotherapy and Oncology. 2022 May;170:S321-S3. PubMed PMID: WOS:000806759200323.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/625527
    Type
    Meetings and Proceedings
    Collections
    All Paterson Institute for Cancer Research

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.